Plectranthus aliciae Extract for Acne and Hyperpigmentation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current acne therapies, including tetracycline and topical treatments, face challenges such as antibiotic resistance, skin irritation, and the risk of photodamage, while treatments for post-inflammatory hyperpigmentation (PIH) can be harmful and ineffective, especially for darker skin tones.
Innovation Solution
A topical pharmaceutical composition derived from Plectranthus aliciae extract, which includes a pharmaceutically acceptable carrier, is developed to address acne and PIH, featuring antibacterial, anti-inflammatory, and antioxidant properties, reducing the appearance of acne lesions and hyperpigmentation without causing irritation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If tetracycline or doxycycline is used to treat acne, then antibacterial effect against Cutibacterium acnes is improved, but antibiotic resistance develops and photodamage occurs
Solution Approach 1:
The patent replaces conventional antibiotics (tetracycline, doxycycline) with plant-derived extracts from Plectranthus aliciae and other botanical sources. These natural extracts serve as short-term, disposable alternatives that do not contribute to antibiotic resistance. The extracts are applied topically and provide effective antibacterial action against C. acnes without the long-term resistance issues associated with conventional antibiotics.
Solution Approach 2:
The patent introduces plant extracts as intermediary substances that mediate between the need for antibacterial treatment and the avoidance of harmful side effects. These extracts contain multiple bioactive compounds (flavonoids, phenolic acids, terpenes) that work synergistically to provide antibacterial, anti-inflammatory, and photoprotective effects, replacing the need for conventional antibiotics and their harmful byproducts.
2Reliability
If topical therapies are used to prevent comedone formation, then acne prevention is improved, but skin irritation and damage occur
Solution Approach 1:
The patent employs composite formulations containing multiple plant extracts (Plectranthus aliciae, Aloe vera, Centella asiatica, Chamomile) combined with pharmaceutical excipients. This composite approach creates a synergistic effect where different plant compounds work together to prevent comedone formation through multiple mechanisms (anti-inflammatory, antioxidant, sebaceous gland regulation) while the soothing components mitigate irritation and skin damage.
Solution Approach 2:
The patent modifies the chemical parameters of topical treatments by using plant-derived compounds with different molecular structures and properties compared to conventional acne medications. These natural compounds exhibit gentler interactions with skin proteins and cell membranes, reducing irritation while maintaining effectiveness in preventing comedone formation through regulation of keratinization and sebum production.
3Manufacturing precision
If current therapies for post-inflammatory hyperpigmentation are used, then pigmentation lightening is improved, but skin harm and worsening of PIH occur
Solution Approach 1:
The patent converts potentially harmful conventional depigmenting agents into beneficial plant-based alternatives. The plant extracts contain natural tyrosinase inhibitors (flavonoids, phenolic compounds) that gently reduce melanin production without the harsh side effects of chemical peels or strong depigmenting agents. The anti-inflammatory properties of these extracts also prevent further irritation that could worsen PIH, effectively converting the harmful irritation pathway into a beneficial soothing effect.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The Plectranthus aliciae extract composition effectively reduces acne lesions and PIH by inhibiting Cutibacterium acnes, reducing inflammation, and preventing hyperpigmentation, while being non-irritant and safe for use on the skin, offering a natural, cost-effective alternative to existing treatments.
Implementation Method 1
The Plectranthus aliciae extract composition effectively reduces acne lesions and PIH by inhibiting Cutibacterium acnes
Implementation Method 2
featuring antibacterial, anti-inflammatory, and antioxidant properties, reducing the appearance of acne lesions and hyperpigmentation
Implementation Method 3
featuring antibacterial, anti-inflammatory, and antioxidant properties, reducing the appearance of acne lesions and hyperpigmentation
Data Source
AI summary
The invention provides a pharmaceutical composition suitable for topical application. The pharmaceutical composition comprises an extract of Plectranthus aliciae and a pharmaceutically acceptable carrier. The invention extends to provide a pharmaceutical composition for the treatment of acne, a pharmaceutical gel composition, a substance or composition comprising an extract of Plectranthus aliciae, a use of a Plectranthus aliciae extract, and various methods of preventing or treating acne.